Keenova Therapeutics plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin 15
SEC filing record 1 source field available
Fiscal year end
31 December
Keenova Therapeutics plc has filed 1,437 SEC EDGAR filings since 01 Feb 2013

SEC filing history

Showing 651-675 of 1,000 matching filings.

Per page
25
Current page
27
SC 13G File 005-87833

SC 13G filing

Filing date
03 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jul 2019
Reporting date
01 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

8-K 06.27.19

Filing date
27 Jun 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87833

SCHEDULE 13G/A

Filing date
10 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2019
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jun 2019
Reporting date
01 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jun 2019
Reporting date
30 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2019
Reporting date
30 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-35803

SD

Filing date
31 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

8-K 28.05.19

Filing date
28 May 2019
Reporting date
28 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 May 2019
Reporting date
22 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
24 May 2019
Reporting date
22 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

8-K 05.15.2019

Filing date
21 May 2019
Reporting date
21 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

8-K

Filing date
21 May 2019
Reporting date
21 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35803

DEFA14A

Filing date
09 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .